Percutaneous endovascular embolization of intracerebral arteriovenous malformations. Experience in 72 cases.
Endovascular therapeutic embolization of arteriovenous malformations (AVMs) of the brain was performed in 72 patients between October 1986 and March 1993. From October 1986 to May 1991, 38 patients in this series were treated with isobuty1-2-cyanoacrylate (IBCA) glue. After June 1991, in the remaining 34 patients the embolic materials used included surgical silk (5-0), polyvinyl alcohol (PVA), ethanol, and estrogen. After treatment, 29 patients (40.3%) had complete angiographic obliteration of AVM, 15 (21%) transient neurologic postembolization deficit, and 3 (4%) permanent deficit without death. Embolic agents and procedures are discussed as to their curative effects, safety, normal perfusion pressure breakthrough (NPPB) problem, with silk mixture fluid being considered preferable.
Huang
Z
Z
Department of Neurosurgery, First Hospital, Harbin Medical University.
Dai
Q
Q
Suo
J
J
Liu
F
F
Wang
C
C
Yin
W
W
D000293:Adolescent; D000328:Adult; D002015:Bucrylate / Q000627:therapeutic use; D002648:Child; D004621:Embolization, Therapeutic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D002538:Intracranial Arteriovenous Malformations / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D014014:Tissue Adhesives / Q000627:therapeutic use
D014014:Tissue Adhesives; D002015:Bucrylate